Myxofibrosarcoma directly invading superior vena cava causing obstruction successfully relieved by endovascular stent

References

• Merck C, Angervall L, Kindblom LG, Odén A. Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic- histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl 1983;282:1–40.
   PubMedGoogle Scholar
• Hambleton C, Noureldine S, Gill F, Moroz K, Kandil E. Myxofibrosarcoma with metastasis to the lungs, pleura, and mediastinum: A case report and review of literature. Int J Clin Exp Med 2012;5:92–5.
   PubMed Web of Science ®Google Scholar
• Sanfilippo R, Miceli R, Grosso F, Fiore M, Puma E, Pennacchioli E, et al. Myxofibrosarcoma: Prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol 2011;18:720–5.
   PubMed Web of Science ®Google Scholar
• Huang HY, Lal P, Qin J, Brennan MF, Antonescu CR. Low-grade myxofibrosarcoma: A clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol 2004;35:612–21.
   PubMed Web of Science ®Google Scholar
• Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996;20:391–405.
   PubMed Web of Science ®Google Scholar
• Wada T, Hasegawa T, Nagoya S, Kawaguchi S, Kaya M, Ishii S. Myxofibrosarcoma with an infiltrative growth pattern: A case report. Jpn J Clin Oncol 2000;30:458–62.
   PubMed Web of Science ®Google Scholar
• Mansoor A, White CR Jr. Myxofibrosarcoma presenting in the skin: Clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms. Am J Dermatopathol 2003;25:281–6.
   PubMed Web of Science ®Google Scholar
• Mutter RW, Singer S, Zhang Z, Brennan MF, Alektiar KM. The enigma of myxofibrosarcoma of the extremity. Cancer 2012;118:518–27.
   PubMed Web of Science ®Google Scholar
• Dewan V, Darbyshire A, Sumathi V, Jeys L, Grimer R. Prognostic and survival factors in myxofibrosarcomas. Sarcoma 2012;2012:830879.
   PubMedGoogle Scholar
• Thakker M, Keteepe-Arachi T, Abbas A, Barker G, Ruparelia N, Kingston GT, et al. A primary cardiac sarcoma presenting with superior vena cava obstruction. Am J Emerg Med 2012;30:264.e3–5.
   Google Scholar
• Shaikh I, Berg K, Kman N. Thrombogenic catheter- associated superior vena cava syndrome. Case Rep Emerg Med 2013;2013:793054.
   PubMedGoogle Scholar
• Nasser F, Cavalcante RN, Galastri FL, Affonso BB. Use of transoesophageal echocardiography in endovascular stenting for superior vena cava syndrome. BMJ Case Rep 2013; 2013. pii: bcr2013010356.
   PubMedGoogle Scholar
• Portillo-Sanchez J, Hessein-Abdou Y, Puga-Alcalde E, Perez-Martinez MA, Del Carmen Jimenez-Meneses M, Camacho-Pedrero A, et al. Primary pulmonary artery sarcoma extending retrograde into the superior vena cava. Tex Heart Inst J 2011;38:77–80.
   PubMed Web of Science ®Google Scholar
• Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: Metal stents or radiation therapy. J Vasc Interv Radiol 1997; 8:781–8.
   PubMed Web of Science ®Google Scholar
• Lanciego C, Pangua C, Chacón JI, Velasco J, Boy RC, Viana A, et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol 2009;193:549–58.
   PubMed Web of Science ®Google Scholar
• Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 2006;29:319–22.
   PubMed Web of Science ®Google Scholar
• Sheikh MA, Fernandez BB Jr, Gray BH, Graham LM, Carman TL. Endovascular stenting of nonmalignant superior vena cava syndrome. Catheter Cardiovasc Interv 2005; 65:405–11.
   PubMed Web of Science ®Google Scholar
• Gross CM, Krämer J, Waigand J, Uhlich F, Schröder G, Thalhammer C, et al. Stent implantation in patients with superior vena cava syndrome. AJR Am J Roentgenol 1997;169:429–32.
   PubMed Web of Science ®Google Scholar
• Lee JC, Li CF, Fang FM, Wang JW, Jeng YM, Yu SC, et al. Prognostic implication of MET overexpression in myxofibrosarcomas: An integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis. Mod Pathol 2010;23:1379–92.
   PubMed Web of Science ®Google Scholar
• van der Graaf WT, Gelderblom H. New systemic therapy options for advanced sarcomas. Curr Treat Options Oncol 2012;13:306–17.
   PubMed Web of Science ®Google Scholar